Effects of ranolazine on exercise capacity, right ventricular indices, and hemodynamic characteristics in pulmonary arterial hypertension: a pilot study

Abstract. Ranolazine, a late inward sodium current and fatty acid oxidation inhibitor, may improve right ventricular (RV) function in pulmonary arterial hypertension (PAH); however, the safety and efficacy of ranolazine in humans with PAH is unknown. Therefore, we sought to (1) determine whether ran...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Pulm Circ
Hoofdauteurs: Khan, Sadiya S., Cuttica, Michael J., Beussink-Nelson, Lauren, Kozyleva, Anastasia, Sanchez, Cynthia, Mkrdichian, Hamorabi, Selvaraj, Senthil, Dematte, Jane E., Lee, Daniel C., Shah, Sanjiv J.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: University of Chicago Press 2015
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4556506/
https://ncbi.nlm.nih.gov/pubmed/26401256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/682427
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items